Gene Therapy for Deafness Moves a Step Closer

Mutations in the protein, otoferlin, are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing.

Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

Mutations in the protein, otoferlin, are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing.

Occupational Hearing Loss - Identification and Prevention
Noise-Induced hearing loss is one of the major avoidable causes of hearing loss and is also one of the major occupational hazards.

‘Mutation in otoferlin weakens the binding between the protein and a calcium synapse in the ear, and deficiencies in that interaction might be at the root of hearing loss related to otoferlin.’

The research suggests otoferlin, which is in the cochlea of the inner ear, acts as a calcium-sensitive linker protein. The study also shows that a mutation in otoferlin weakens the binding between the protein and a calcium synapse in the ear, and deficiencies in that interaction might be at the root of hearing loss related to otoferlin.

The size of the otoferlin molecule and its low solubility have made it difficult to study, including how otoferlin works differently than another neuronal calcium sensor in the brain, synaptotagmin.

To combat those challenges, researchers in OSU's College of Science developed a single-molecule colocalization binding titration assay - smCoBRA - for quantitatively probing otoferlin.

Single Side Deafness in India Being Treated with 'Bone Anchored Hearing Aid'
With close to 200,000 new cases of single side deafness being diagnosed in India every year, you can opt for this treatment at the cost of Rs.2.5 lakh.

"It's a one-trick pony of a protein," said corresponding author Colin Johnson, associate professor of biochemistry and biophysics. "A lot of genes will find various things to do, but otoferlin seems only to have one purpose and that is to encode sound in the sensory hair cells in the inner ear. And small mutations in otoferlin render people profoundly deaf."

The work by Johnson and collaborators in the Department of Physics and Department of Biochemistry and Biophysics provides a molecular-level explanation for the observation that otoferlin and synaptotagmin don't have the same functional role.

Scientists Find How Mutant Gene can Cause Deafness
At The Scripps Research Institute (TSRI), scientists have discovered how one gene is essential to hearing, uncovering a cause of deafness and suggesting new avenues for therapies.

The research, performed using recombinant protein from cell lysate isolated in vitro, also validates a methodology for characterizing large, multivalent membrane proteins in general.

"The otoferlin gene is really big, and it makes a huge protein," Johnson said. "The traditional method for making a recombinant protein is using E. coli, but they loathe big proteins. This paper came up with a way of getting around that challenge.

Highlighting the Importance of Rare Disease Research
The importance of rare disease research is highlighted by the discovery of deafness-dystonia syndrome, reveals study.

"We were trying to shorten the gene, to find a truncated form that can be used for gene therapy. There is a size limit in terms of what you can package into the gene delivery vehicle, and otoferlin is too large. That's the holy grail, trying to find a miniature version of otoferlin that that can be packaged into the delivery vehicle and then hopefully the patient can start hearing."

Otoferlin's size has precluded rescue experiments in which a modified mRNA for otoferlin is transfected into an animal model to replace a suppressed or knocked-down otoferlin gene causing deafness.

The study by Johnson, doctoral biochemistry student Nicole Hams, former biochemistry doctoral student Murugesh Padmanaryana and biophysicist Weihong Qiu identified a truncated form of otoferlin that can function in the encoding of sound.

The National Institutes of Health supported this study. Findings were recently published in the Proceedings of the National Academy of Sciences.

Source-Eurekalert